IPG Health announced a new clinical trial diversity offering aimed at ensuring equitable representation across various aspects of diversity, including race, gender, age, and other intersectional groups in clinical trials. This offering is part of its EDI+You strategy, which seeks to provide inclusive solutions across more than 45 agencies. Underrepresentation in clinical trials, particularly among black and Native American communities, has been a concern for the healthcare sector, a situation accentuated by COVID-19-related racial health disparities. IPG Health hopes the diversity focus will help address health inequity and assist in unlocking new opportunities for underserved communities.
To read more, click here.
[Source: MM+M, September 6th, 2023]